DEYZOLY
Live / Applied — New application — assigned to an examiner (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 27 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79446709
- Mark type
- Stylized text
- Filed
- 27 Nov 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely for treatment and prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical preparations, namely for treatment and prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); pharmaceutical preparations, namely for treatment of human patients suffering from CHI (Congenital HyperInsulinism) and/or hypoglycemia; medical preparations for the treatment of human patients suffering from CHI (Congenital HyperInsulinism) and/or hypoglycemia.
- Class 010 — Medical apparatus: Devices for introducing pharmaceutical preparations, namely for treatment and prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS), and parts and fittings therefor; devices for introducing pharmaceutical preparations, namely for treatment of human patients suffering from CHI (Congenital HyperInsulinism) and/or hypoglycemia, and parts and fittings therefor.
- Class 044 — Medical, beauty and agricultural services: Medical and pharmaceutical services, namely in relation to treatment and prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical and pharmaceutical advice, namely in relation to treatment and prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical and pharmaceutical services, namely in relation to treatment of human patients suffering from CHI (Congenital HyperInsulinism) and/or hypoglycemia; medical and pharmaceutical advice, namely in relation to treatment of human patients suffering from CHI (Congenital HyperInsulinism) and/or hypoglycemia.
Owner
Prosecution history
- 31 Mar 2026 — ASSIGNED TO EXAMINER
- 27 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 27 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Mar 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB